The role of ASMase-derived ceramides in pulmonary inflammation is highlighted by their involvement in platelet-activating factor (PAF)-induced pulmonary edema (125), as well as in the pathology of cystic fibrosis (123). This evidence concerns the gene SMPD1 and pulmonary edema.